New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404 …,

LY-CoV1404 enters clinical trials as part of Lilly’s BLAZE-4 study in patients … has entered clinical trials in patients with mild-to-moderate COVID-19., LY-CoV1404 enters clinical trials as part of Lilly’s BLAZE-4 study in patients … has entered clinical trials in patients with mild-to-moderate COVID-19., Read More

Scroll to Top